Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort

References

• Hollander DD, Kampman E, van Herpen CM. Pretreatment body mass index and head and neck cancer outcome: A review of the literature. Crit Rev Oncol Hematol 2015 Jun 18; pii: S1040-8428(15)00120-1; 96(2)
   PubMed Web of Science ®Google Scholar
• Aune D, Navarro Rosenblatt DA, Chan DS, Vingeliene S, Abar L, Vieira AR, Greenwood DC, Bandera EV, Norat T. Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Ann Oncol 2015 Aug;26(8):1635-48; http://dx.doi.org/10.1093/annonc/mdv142
   PubMed Web of Science ®Google Scholar
• James FR, Wootton S, Jackson A, Wiseman M, Copson ER, Cutress RI. Obesity in breast cancer–what is the risk factor? Eur J Cancer 2015 Apr;51(6):705-20; http://dx.doi.org/10.1016/j.ejca.2015.01.057
   PubMed Web of Science ®Google Scholar
• Sharma A, Lavie CJ, Borer JS, Vallakati A, Goel S, Lopez-Jimenez F, Arbab-Zadeh A, Mukherjee D, Lazar JM. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol 2015 May 15; 115(10):1428-34; http://dx.doi.org/10.1016/j.amjcard.2015.02.024
   PubMed Web of Science ®Google Scholar
• Yatsuya H, Li Y, Hilawe EH, Ota A, Wang C, Chiang C, Zhang Y, Uemura M, Osako A, Ozaki Y, Aoyama A. Global trend in overweight and obesity and its association with cardiovascular disease incidence. Circ J 2014; 78(12):2807-18; PMID:25391910; http://dx.doi.org/10.1253/circj.CJ-14-0850
   PubMed Web of Science ®Google Scholar
• De Miguel-Etayo P, Mesana MI, Cardon G, De Bourdeaudhuij I, Góźdź M, Socha P, Lateva M, Iotova V, Koletzko BV, Duvinage K, et al. ToyBox-study group. Reliability of anthropometric measurements in European preschool children: the ToyBox-study. Obes Rev 2014 Aug;15 Suppl 3:67-73; http://dx.doi.org/10.1111/obr.12181
   PubMed Web of Science ®Google Scholar
• Chan DS, Norat T. Obesity and breast cancer: not only a risk factor of the disease. Curr Treat Options Oncol 2015 May; 16(5):22; http://dx.doi.org/10.1007/s11864-015-0341-9
   PubMed Web of Science ®Google Scholar
• Keum N, Greenwood DC, Lee DH, Kim R, Aune D, Ju W, Hu FB, Giovannucci EL. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst 2015 Mar 10; 107(2); http://dx.doi.org/10.1093/jnci/djv088
   Google Scholar
• Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 2012; 62:243-74; PMID:22539238; http://dx.doi.org/10.3322/caac.21142
   PubMed Web of Science ®Google Scholar
• Courneya KS, Segal RJ, McKenzie DC, Dong H, Gelmon K, Friedenreich CM, Yasui Y, Reid RD, Crawford JJ, Mackey JR. Effects of exercise during adjuvant chemotherapy on breast cancer outcomes. Med Sci Sports Exerc 2014; 46:1744-51; PMID:24633595; http://dx.doi.org/10.1249/MSS.0000000000000297
   PubMed Web of Science ®Google Scholar
• Reeves MM, Terranova CO, Eakin EG, Demark-Wahnefried W. Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev 2014; 15:749-68; PMID:24891269; http://dx.doi.org/10.1111/obr.12190
   PubMed Web of Science ®Google Scholar
• Goodwin PJ, Segal RJ, Vallis M, Ligibel JA, Pond GR, Robidoux A, Blackburn GL, Findlay B, Gralow JR, Mukherjee S, et al. Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial. J Clin Oncol 2014; 32:2231-9; PMID:24934783; http://dx.doi.org/10.1200/JCO.2013.53.1517
   PubMed Web of Science ®Google Scholar
• Goodwin PJ, Parulekar WR, Gelmon KA, et al. Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC). J Clin Oncol 2013; 31 (suppl; abstr 1033)
   Google Scholar
• Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008; 26:3324-30; PMID:18612148; http://dx.doi.org/10.1200/JCO.2007.14.2471
   PubMed Web of Science ®Google Scholar
• Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol 2009 Jun;36(3):237-49; http://dx.doi.org/10.1053/j.seminoncol.2009.03.001
   PubMed Web of Science ®Google Scholar
• Hofvind S, Lee CL, Elmore JG. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program. Breast Cancer Res Treat 2012; 135:291-9; PMID:22833199; http://dx.doi.org/10.1007/s10549-012-2162-x
   PubMed Web of Science ®Google Scholar
• Burg MA, Adorno G, Lopez ED, Loerzel V, Stein K, Wallace C, Sharma DK. Current unmet needs of cancer survivors: analysis of open-ended responses to the American Cancer Society Study of Cancer Survivors II. Cancer 2015 Feb 15; 121(4):623-30; http://dx.doi.org/10.1002/cncr.28951
   PubMed Web of Science ®Google Scholar
• Fontanella C, Lederer B, Gade S, Vanoppen M, Blohmer JU, Costa SD, Denkert C, Eidtmann H, Gerber B, Hanusch C, et al. Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials. Breast Cancer Res Treat 2015 Feb; 150(1):127-39. Epub 2015 Feb 13; http://dx.doi.org/10.1007/s10549-015-3287-5
   PubMed Web of Science ®Google Scholar
• Loibl S, Jackisch C, Lederer B, Untch M, Paepke S, Kümmel S, Schneeweiss A, Huober J, Hilfrich J, Hanusch C, et al. Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials. Breast Cancer Res Treat 2015 Jul;152(2):377-87; http://dx.doi.org/10.1007/s10549-015-3479-z
   PubMed Web of Science ®Google Scholar
• http://www.underforty.it/, last accessed in August 2015.
   Google Scholar
• Recht A, Gray R, Davidson NE, Fowble BL, Solin LJ, Cummings FJ, Falkson G, Falkson HC, Taylor SG, 4th, Tormey DC. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17:1689-700; PMID:10561205
   PubMed Web of Science ®Google Scholar
• Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary SE, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000; 18:2817-27; PMID:10920129; http://dx.doi.org/10.1002/jcp.25213
   PubMed Web of Science ®Google Scholar
• Wallgren A, Bonetti M, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Holmberg SB, Lindtner J, Thürlimann B, Fey M, Werner ID, et al International Breast Cancer Study Group Trials I through VII Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 2003; 21:1205-13; PMID:12663706; http://dx.doi.org/10.1200/JCO.2003.03.130
   PubMed Web of Science ®Google Scholar
• Taghian A, Jeong JH, Mamounas E, Anderson S, Bryant J, Deutsch M, Wolmark N. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2004; 22:4247-54; PMID:15452182; http://dx.doi.org/10.1200/JCO.2004.01.042
   PubMed Web of Science ®Google Scholar
• Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and longterm clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet (2014); 384:164-172; PMID:24529560; http://dx.doi.org/10.1016/S0140-6736(13)62422-8
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B, Senn HJ, Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 2013 Sep; 24(9):2206-23; http://dx.doi.org/10.1093/annonc/mdt303
   PubMed Web of Science ®Google Scholar
• http://apps.who.int/bmi/index.jsp, last accessed in October 2015.
   Google Scholar
• Barba M, Pizzuti L, Sperduti I, Natoli C, Gamucci T, Sergi D, Di Lauro L, Moscetti L, Izzo F, Rinaldi M, et al. Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated with Eribulin. J Cell Physiol 2015 Oct 9
   Web of Science ®Google Scholar
• Widschwendter P, Friedl TW, Schwentner L, DeGregorio N, Jaeger B, Schramm A, Bekes I, Deniz M, Lato K, Weissenbacher T, et al. The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial. Breast Cancer Res 2015 Sep 18; 17:129; http://dx.doi.org/10.1186/s13058-015-0639-3
   PubMed Web of Science ®Google Scholar
• Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, Navarro Rosenblatt D, Thune I, Vieira R, Norat T. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 2014 Oct;25(10):1901-14; http://dx.doi.org/10.1093/annonc/mdu042
   PubMed Web of Science ®Google Scholar
• Hursting SD, Berger NA. Energy balance, host-related factors, and cancer progression. J Clin Oncol 2010; 28:4058-4065; PMID:20697088; http://dx.doi.org/10.1200/JCO.2010.27.9935
   PubMed Web of Science ®Google Scholar
• Lonning PE. Aromatase inhibition for breast cancer treatment. Acta Oncol 1996; 35(Suppl 5):38-43; PMID:9142963; http://dx.doi.org/10.3109/02841869609083966
   PubMed Web of Science ®Google Scholar
• Goodwin PJ, Ennis M, Bahl M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, Hood N. High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat 2009; 114:517-525; PMID:18437560; http://dx.doi.org/10.1007/s10549-008-0019-0
   PubMed Web of Science ®Google Scholar
• Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, Hood N. Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 2005; 23:6037-6042; PMID:16135472; http://dx.doi.org/10.1200/JCO.2005.02.048
   PubMed Web of Science ®Google Scholar
• Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009; 27:3437-3444; PMID:19470939; http://dx.doi.org/10.1200/JCO.2008.18.9068
   PubMed Web of Science ®Google Scholar
• Carvalho FM, Bacchi LM, Santos PP, Bacchi CE. Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients. Clinics (Sao Paulo) 2010; 65:1033-6; PMID:21120307; http://dx.doi.org/10.1590/S1807-59322010001000019
   PubMed Web of Science ®Google Scholar
• Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-DeMore N, Perou CM. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 2011; 29:e18-20; PMID:21115855; http://dx.doi.org/10.1200/JCO.2010.28.9199
   PubMed Web of Science ®Google Scholar
• Chen HL, Ding A, Wang FW. Prognostic effect analysis of molecular subtype on young breast cancer patients. Chin J Cancer Res 2015 Aug; 27(4):428-36; http://dx.doi.org/10.3978/j.issn.1000-9604
   PubMed Web of Science ®Google Scholar
• Chapman CH, Jagsi R. Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy: A Review of the Evidence. Oncology (Williston Park) 2015 Sep; 29(9). pii: 213357; PMID:26384802
   Google Scholar
• Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet 2005 Jan 1–7; 365(9453):82-93; http://dx.doi.org/10.1016/S0140-6736(04)17670-8
   PubMed Web of Science ®Google Scholar
• American Cancer Society (2011) Breast cancer facts and figures 2011–2012. http://www.cancer.org/research/cancerfactsfigures/breastcancerfactsfigures/breast-cancer-facts-and-figures-2011-2012. Accessed 4 Nov 2013.
   Google Scholar
• Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD. Functional impact of breast cancer by age at diagnosis. J Clin Oncol 2004 May 15; 22(10):1849-56; http://dx.doi.org/10.1200/JCO.2004.04.173
   PubMed Web of Science ®Google Scholar